Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leoclan CoTSE:7681 64 Receivables Turnover is 1.59 as of Mar. 2026. GuruFocus rates TSE:7681 with a GF Score™ of 64/100 and a GF Value™ of 円1,351.64 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 118 Medical Distribution companies, Leoclan Co ranks worse than 50.85% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Leoclan Co's Revenue for the
three
months ended in Mar. 2026 was 円13,908 Mil. Leoclan Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was 円8,758 Mil.
Hence, Leoclan Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.59.
Leoclan Co (TSE:7681) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Leoclan Co Receivables Turnover Related Terms
Leoclan Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Leoclan Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7681 vs MCK, COR, CAH: Receivables Turnover Comparison
For the Medical Distribution subindustry, Leoclan Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leoclan Co Receivables Turnover vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Leoclan Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Leoclan Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leoclan Co (TSE:7681) has a Receivables Turnover of 1.59 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Leoclan Co and its competitors. According to the industry distribution chart, Leoclan Co ranks #60 out of 118 companies in the Medical Distribution industry, placing it in the top 50.8%.
Is Leoclan Co's Receivables Turnover too high?
Leoclan Co's current Receivables Turnover is 1.59. The Medical Distribution industry median Receivables Turnover is 4.64. Leoclan Co's value of 1.59 is 65.7% below this industry median. Based on the distribution chart, Leoclan Co ranks #60 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Leoclan Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Leoclan Co's Receivables Turnover compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Leoclan Co ranks #60 out of 118 companies for Receivables Turnover. This places Leoclan Co in the lower half of its industry. The industry median Receivables Turnover is 4.64. Leoclan Co's value of 1.59 is 65.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.64, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leoclan Co's current Receivables Turnover of 1.59 is 65.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Leoclan Co and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leoclan Co's current Receivables Turnover is 1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leoclan Co stock overvalued right now?
Based on GuruFocus' analysis, Leoclan Co (TSE:7681) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,351.64, compared to a current price of 円966.00 — trading 28.5% below its estimated fair value. The current Receivables Turnover is 1.59 and 65.7% below the Medical Distribution industry median of 4.64. Leoclan Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Leoclan Co (TSE:7681), the current Receivables Turnover is 1.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leoclan Co (TSE:7681) Overvalued in 2026?
Based on GuruFocus' analysis, Leoclan Co stock appears to be undervalued.
The current stock price of 円966.00 is trading 28.5% below its estimated GF Value™ of 円1,351.64.
GuruFocus considers Leoclan Co to be Modestly Undervalued.
Key valuation signals for TSE:7681:
Receivables Turnover: 1.59
GF Value™: 円1,351.64 vs. price of 円966.00 (28.5% below fair value)
Industry Position: 65.7% below the Medical Distribution median (#60 of 118)
No single metric tells the full story. See the TSE:7681 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7681 has been successfully added to your 
